ORIGINAL_ARTICLE
Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial
BACKGROUND: Although the antioxidant properties of ginger have been revealed, there is little available information on the effectiveness of ginger on inflammatory disorders such as atherosclerosis. This study was carried out to examine the effect of ginger on improving the complication of atherosclerosis.METHODS: This study was a double-blind, placebo-controlled, randomized clinical trial conducted on patients with atherosclerosis. Participants in the ginger and control groups received 1600 mg of powdered ginger or placebo (wheat flour) in capsules daily for 8 weeks. Weight, body mass index (BMI), fasting blood sugar (FBS), cholesterol, triglyceride (TG), low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), high-density lipoprotein (HDL), lipoprotein (a) [Lp(a)], high-sensitivity C-reactive protein (hs-CRP), and total anti-oxidant capacity (TAC) were assessed before and after the intervention.RESULTS: Ginger consumption in the intervention group significantly reduced serum Lp(a) level (27.25 ± 1.30 ng/ml vs. 23.57 ± 0.97 ng/ml) (P = 0.040) and also the level of hs-CRP in the intervention group was 1.90 ± 0.33 µg/ml and 1.24 ± 0.15 µg/ml (P = 0.010) before and after intervention, respectively, but the levels of Lp(a) and hs-CRP were not decreased significantly in the placebo group. The level of TAC in the ginger group was 0.71 ± 0.05 mM and after the trial was 0.57 ± 0.04 mM (P = 0.050); no significant differences were seen in TAC when ginger was administered at 1600 mg/daily for 60 days. Also the level of Lp(a) and hs-CRP but not TAC reduced significantly in ginger group compared to placebo group after intervention.CONCLUSION: This study showed that ginger had anti-atherosclerosis and anti-glycemic properties associated through a significant decreased Lp(a) and FBS in patients with atherosclerosis supplemented with ginger.
https://arya.mui.ac.ir/article_10736_c9bd66483af5bbfeed216490e807fcd5.pdf
2020-09-09
153
160
10.22122/arya.v16i4.2011
Atherosclerosis
Ginger
Lipoprotein (a)
C-Reactive Protein
Oxygen Radical Absorbance Capacity
Hossein
Babaahmadi-Rezaei
babaahmadi@mailinator.com
1
Associate Professor, Cellular and Molecular Research Center AND Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
AUTHOR
Alireza
Kheirollah
kheirollah@mailinator.com
2
Associate Professor, Cellular and Molecular Research Center AND Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
AUTHOR
Saeed
Hesam
hesam@mailinator.com
3
Assistant Professor, Department of Biostatistics and Epidemiology, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
AUTHOR
Saleh
Ayashi
ayashi@mailinator.com
4
PhD Candidate, Cellular and Molecular Research Center AND Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
AUTHOR
Mohammad
Aberumand
aberumand@mailinator.com
5
Associate Professor, Cellular and Molecular Research Center AND Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
AUTHOR
Mohammad Hassan
Adel
adel@mailinator.com
6
Associate Professor, Atherosclerosis Research Center AND Department of Cardiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
AUTHOR
Masoumeh
Zamanpour
zamanpour@mailinator.com
7
Cellular and Molecular Research Center AND Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
AUTHOR
Maryam
Alasvand
alasvand@mailinator.com
8
Assistant Professor, Atherosclerosis Research Center AND Department of Cardiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
AUTHOR
Zohreh
Amozgari
amozgari@mailinator.com
9
Lecturer, Cellular and Molecular Research Center AND Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
AUTHOR
Mojgan
Noor-Behbahani
noor@mailinator.com
10
Cellular and Molecular Research Center AND Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
AUTHOR
Zahra
Niknam
zahraniknam22@yahoo.com
11
Cellular and Molecular Research Center AND Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
LEAD_AUTHOR
Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352(16): 1685-95.
1
Mackay J, Mensah GA. The atlas of heart disease and stroke. Geneva, Switzerland: World Health Organization; 2004.
2
Libby P. What have we learned about the biology of atherosclerosis? The role of inflammation. Am J Cardiol 2001; 88(7B): 3J-6J.
3
Nordestgaard BG, Chapman MJ, Ray K, Boren J, Andreotti F, Watts GF, et al. Lipoprotein(a) as a cardiovascular risk factor: Current status. Eur Heart J 2010; 31(23): 2844-53.
4
Raal FJ, Giugliano RP, Sabatine MS, Koren MJ, Blom D, Seidah NG, et al. PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: An analysis of 10 clinical trials and the LDL receptor's role. J Lipid Res 2016; 57(6): 1086-96.
5
Kassner U, Schlabs T, Rosada A, Steinhagen-Thiessen E. Lipoprotein(a)--An independent causal risk factor for cardiovascular disease and current therapeutic options. Atheroscler Suppl 2015; 18: 263-7.
6
Kooti W, Mansouri E, Ghasemiboroon M, Harizi M, Ashtary-Larky D, Afrisham R. The Effects of Hydroalcoholic Extract of Apium graveolens Leaf on the Number of Sexual Cells and Testicular Structure in Rat. Jundishapur J Nat Pharm Prod 2014; 9(4): e17532.
7
Mitra B, Panja M. High sensitive C-reactive protein: A novel biochemical markers and its role in coronary artery disease. J Assoc Physicians India 2005; 53: 25-32.
8
Wang Y, Chun OK, Song WO. Plasma and dietary antioxidant status as cardiovascular disease risk factors: A review of human studies. Nutrients 2013; 5(8): 2969-3004.
9
Werneke U, Earl J, Seydel C, Horn O, Crichton P, Fannon D. Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer 2004; 90(2): 408-13.
10
Grzanna R, Lindmark L, Frondoza CG. Ginger--an herbal medicinal product with broad anti-inflammatory actions. J Med Food 2005; 8(2): 125-32.
11
Jiang X, Blair EY, McLachlan AJ. Investigation of the effects of herbal medicines on warfarin response in healthy subjects: A population pharmacokinetic-pharmacodynamic modeling approach. J Clin Pharmacol 2006; 46(11): 1370-8.
12
Frostegard J. SLE, atherosclerosis and cardiovascular disease. J Intern Med 2005; 257(6): 485-95.
13
Tietge UJ. Hyperlipidemia and cardiovascular disease: Inflammation, dyslipidemia, and atherosclerosis. Curr Opin Lipidol 2014; 25(1): 94-5.
14
Shirali S, Shokri Mashhadi N, Ashtary-Larky D, Safania T, Barari A. Effects of silymarin supplementation on leptin, adiponectin and paraoxanase levels and body composition during exercise: A randomized double-blind placebo controlled clinical trial. Jundishapur J Nat Pharm Prod 2017; 11(4).
15
Kooti W, Hasanzadeh-Noohi Z, Sharafi-Ahvazi N, Asadi-Samani M, Ashtary-Larky D. Phytochemistry, pharmacology, and therapeutic uses of black seed (Nigella sativa). Chin J Nat Med 2016; 14(10): 732-45.
16
Goyal RK, Kadnur SV. Beneficial effects of Zingiber officinale on goldthioglucose induced obesity. Fitoterapia 2006; 77(3): 160-3.
17
Mozaffari-Khosravi H, Talaei B, Jalali BA, Najarzadeh A, Mozayan MR. The effect of ginger powder supplementation on insulin resistance and glycemic indices in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Complement Ther Med 2014; 22(1): 9-16.
18
Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research. Food Chem Toxicol 2008; 46(2): 409-20.
19
Sharpe PA, Granner ML, Conway JM, Ainsworth BE, Dobre M. Availability of weight-loss supplements: Results of an audit of retail outlets in a southeastern city. J Am Diet Assoc 2006; 106(12): 2045-51.
20
Koba S, Hirano T. Dyslipidemia and atherosclerosis. Nihon Rinsho 2011; 69(1): 138-43.
21
Nicoll R, Henein MY. Ginger (Zingiber officinale Roscoe): A hot remedy for cardiovascular disease? Int J Cardiol 2009; 131(3): 408-9.
22
Bordia A, Verma SK, Srivastava KC. Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1997; 56(5): 379-84.
23
Kooti W, Farokhipour M, Asadzadeh Z, Ashtary- Larky D, Asadi-Samani M. The role of medicinal plants in the treatment of diabetes: A systematic review. Electron Physician 2016; 8(1): 1832-42.
24
Shidfar F, Rajab A, Rahideh T, Khandouzi N, Hosseini S, Shidfar S. The effect of ginger (Zingiber officinale) on glycemic markers in patients with type 2 diabetes. J Complement Integr Med 2015; 12(2): 165-70.
25
Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000; 102(10): 1082-5.
26
Bennet A, Di Angelantonio E, Erqou S, Eiriksdottir G, Sigurdsson G, Woodward M, et al. Lipoprotein(a) levels and risk of future coronary heart disease: Large-scale prospective data. Arch Intern Med 2008; 168(6): 598-608.
27
Tsimikas S. Lipoprotein(a): Novel target and emergence of novel therapies to lower cardiovascular disease risk. Curr Opin Endocrinol Diabetes Obes 2016; 23(2): 157-64.
28
Bos S, Yayha R, van Lennep JE. Latest developments in the treatment of lipoprotein (a). Curr Opin Lipidol 2014; 25(6): 452-60.
29
Norata GD, Ballantyne CM, Catapano AL. New therapeutic principles in dyslipidaemia: Focus on LDL and Lp(a) lowering drugs. Eur Heart J 2013; 34(24): 1783-9.
30
Ghafourian M, Ashtary-Larky D, Chinipardaz R, Eskandary N, Mehavaran M. Inflammatory biomarkers' response to two different intensities of a single bout exercise among soccer players. Iran Red Crescent Med J 2016; 18(2): e21498.
31
Arablou T, Aryaeian N, Valizadeh M, Sharifi F, Hosseini A, Djalali M. The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus. Int J Food Sci Nutr 2014; 65(4): 515-20.
32
Mansouri E, Ghasemiboroon M, Asadi Samani M, Alamiri F, Ashtary-Larky D, Kafash Farkhad N, et al. The effect of hydro-alcoholic extract of apium graveolens L. leaf on delivery rate in female rats, weight and gender ratio of infants. Jundishapur J Natur Pharm Products 2017; 12(1): e28802.
33
Stoilova I, Krastanov A, Stoyanova A, Denev P, Gargova S. Antioxidant activity of a ginger extract (Zingiber officinale). Food Chem 2007; 102(3): 764-70.
34
Kamato D, Babaahmadi Rezaei H, Getachew R, Thach L, Guidone D, Osman N, et al. (S)-[6]-Gingerol inhibits TGF-beta-stimulated biglycan synthesis but not glycosaminoglycan hyperelongation in human vascular smooth muscle cells. J Pharm Pharmacol 2013; 65(7): 1026-36.
35
ORIGINAL_ARTICLE
Designing a structural equation model of marital satisfaction based on aging perception and demographic and clinical variables in Iranian elderly patients with coronary artery disease
BACKGROUND: Marital satisfaction is an important variable in maintaining or promoting elderly health. Therefore, identifying the effective factors can increase life expectancy and quality of life. This study aimed to determine the relationship between aging perception and demographic and clinical characteristics with marital satisfaction in the elderly patients with coronary artery disease (CAD).METHODS: This was a descriptive-correlational study. The sample size was 480 elderly patients with CAD who were referred to the heart clinics of hospitals in the west of Mazandaran Province, Iran, who were recruited by convenience sampling. Data were collected by a demographic checklist, ENRICH Marital Satisfaction Inventory, and Aging Perceptions Questionnaire (APQ). The data were analyzed by structural equation model (SEM) using Goodness of Fit Index (GFI and chi-square test. P-value less than 0.050 was considered as significant level.RESULTS: The mean and standard deviation (SD) of marital satisfaction was 145.16 ± 12.12, and the mean and SD of aging perception was 113.39 ± 12.74. The results of the Pearson’s correlation coefficient indicated that the highest correlation was between aging perception and marital satisfaction (r = 0.68, P < 0.001). The model fit indices of the hypothesized model met the criteria, with the GFI = 0.91, Comparative Fit Index (CFI) = 0.93, Normed Fit Index (NFI) = 0.94, and non-Normed Fit Index (NNFI) = 0.91.CONCLUSION: Considering the psychological risk factors affecting marital satisfaction such as aging perception and suitable measurement can lead to marital health and improve treatment outcomes by increasing elderly motivation in self-care. Therefore, the elderly patients with CAD need more serious and long-term educational, counseling, and supportive interventions.
https://arya.mui.ac.ir/article_10737_fe1aeebf87910e42dccb09f9e7035eda.pdf
2020-09-09
161
169
10.22122/arya.v16i4.2087
Structural Equation Modeling
Marital Status
Satisfaction
Perception
Elderly
Coronary Artery Disease
Zahra
Fotokian
fotokian@mailinator.com
1
Assistant Professor, Nursing Care Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
AUTHOR
Ali
Pourhabib
pourhabib@mailinator.com
2
PhD Candidate, School of Nursing and Midwifery, Golestan University of Medical Sciences, Gorgan, Iran
AUTHOR
Nasrin
Navabi
navabi@mailinator.com
3
Lecturer, Nursing Care Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
AUTHOR
Fatemeh
Ghaffari
ghafarifateme@yahoo.com
4
Associate Professor, Nursing Care Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
LEAD_AUTHOR
World Health Organization. Ageing and life course [Online]. [cited 2020]; Available from: URL: https://www.who.int/ageing/en
1
Iran SCI. Mean and Median Age of Iranian Population. Based on the results of the 2016 census [Online]. [cited 2016]; Available from: URL:
2
https://www.amar.org.ir/Portals/1/News/files/Mean%20and%20Median%20Age%20of%20Iranian%20Population.pdf
3
Chiaranai C, Chularee S, Srithongluang S. Older people living with chronic illness. Geriatr Nurs 2018; 39(5): 513-20.
4
Mann DL, Zipes DP, Libby P, Bonow RO. Braunwald's heart disease e-book: A textbook of cardiovascular medicine. Philadelphia, PA: Elsevier Health Sciences; 2014.
5
Aghamohamadi S, Hajinabi K, Jahangiri K, Asl IM, Dehnavieh R. Population and mortality profile in the Islamic Republic of Iran, 2006-2035. East Mediterr Health J 2018; 24(5): 469-76.
6
Bjorvatn A. Hospital readmission among elderly patients. Eur J Health Econ 2013; 14(5): 809-20.
7
Li QP, Mak YW, Loke AY. Spouses' experience of caregiving for cancer patients: A literature review. Int Nurs Rev 2013; 60(2): 178-87.
8
Mroz S, Betkowska-Korpala B, Gierowski K, Kolpa M, Janusz B. Marital relations of patients with myocardial infarction from the spouses' perspective. Archives of Psychiatry and Psychotherapy 2017; 19(4): 42-50.
9
Sarhadi M, Navidian A, Fasihi Harandy T, Ansari Moghadam A. Comparing quality of marital relationship of spouses of patients with and without a history of myocardial infarction. J Health Promot Manag 2013; 2(1): 39-48.
10
Shen S. Chronic disease burden, sexual frequency, and sexual dysfunction in partnered older adults. J Sex Marital Ther 2019; 45(8): 706-20.
11
Chehreh H, Ozgoli G, Abolmaali K, Nasiri M. The relationship between personality traits and marital satisfaction based on five factors model of personality: A systematic review. Sci J Kurdistan Univ Med Sci 2017; 22(5): 121-32. [In Persian].
12
Min J, Yorgason JB, Fast J, Chudyk A. The impact of spouse's illness on depressive symptoms: The roles of spousal caregiving and marital satisfaction. J Gerontol B Psychol Sci Soc Sci 2019.
13
Roberts LR, Schuh H, Sherzai D, Belliard JC, Montgomery SB. Exploring experiences and perceptions of aging and cognitive decline across diverse racial and ethnic groups. Gerontol Geriatr Med 2015; 1.
14
Parish A, Kim J, Lewallen KM, Miller S, Myers J, Panepinto R, et al. Knowledge and perceptions about aging and frailty: An integrative review of the literature. Geriatr Nurs 2019; 40(1): 13-24.
15
Turner LJ. Applying a self-regulation framework to an ageing context: The role of psychosocial mechanisms in relationships between self-perceptions of ageing and mental health [PhD Thesis]; Wollongong, Australia: University of Wollongong; 2018.
16
Warmoth K, Tarrant M, Abraham C, Lang IA. Relationship between perceptions of ageing and frailty in English older adults. Psychol Health Med 2018; 23(4): 465-74.
17
Anahita TB, Sadat IA, Fini IA, Gilasi H, Mirbagher Ajorpaz N. The marital satisfaction and its relative factors among older adults. Nurse Care Open Acces J 2016; 1(4): 63-7.
18
Otero MC, Wells JL, Chen KH, Brown CL, Connelly DE, Levenson RW, et al. Behavioral indices of positivity resonance associated with long-term marital satisfaction. Emotion 2019.
19
Bakhtiyari F, Foroughan M, Fakhrzadeh H, Nazari N, Najafi B, Alizadeh M, et al. Validation of the persian version of abbreviated mental test (AMT) in elderly residents of Kahrizak charity foundation. Iran J Diabetes Lipid Disord 2014; 13(6): 487-94. [In Persian].
20
Hancock GR, Stapleton LM, Mueller RO. The reviewer's guide to quantitative methods in the social sciences. London, UK: Routledge; 2018.
21
Fowers BJ, Olson DH. Enrich marital inventory: A discriminant validity and cross-validation assessment. J Marital Fam Ther 1989; 15(1): 65-79.
22
Arab Alidousti A, Nakhaee N, Khanjani N. Reliability and validity of the Persian versions of the enrich marital satisfaction (brief version) and kansas marital satisfaction scales. Health Develop J 2015; 4(2): 158. [In Persian].
23
Pandya SP. Marital satisfaction of highly qualified professionally achieving women post-retirement: The urban Indian scenario. Journal of Family Studies 2019; 25(1): 61-78.
24
Barker M, O'Hanlon A, McGee HM, Hickey A, Conroy RM. Cross-sectional validation of the Aging Perceptions Questionnaire: A multidimensional instrument for assessing self-perceptions of aging. BMC Geriatr 2007; 7: 9.
25
Yaghoobzadeh A, Sharif Nia H, Hosseinigolafshani Z, Mohammadi F, Oveisi S, Torkmandi H. Associated factors of ageing perception among elderly in Qazvin, 2015. Journal of Gerontology 2017; 1(4): 1-10. [In Persian].
26
Fabrigar LR, Wegener DT, MacCallum RC, Strahan EJ. Evaluating the use of exploratory factor analysis in psychological research. Psychol Methods 1999; 4(3): 272-99.
27
Schermelleh-Engel K, Moosbrugger H, Müller H. Evaluating the fit of structural equation models: Tests of significance and descriptive goodness-of-fit measures. Methods of Psychological Research 2003; 8(2): 23-74.
28
Steverink N, Westerhof GJ, Bode C, Dittmann-Kohli F. The personal experience of aging, individual resources, and subjective well-being. J Gerontol B Psychol Sci Soc Sci 2001; 56(6): 364-73.
29
Fleg JL, Limacher M, Rich MW. Cardiovascular disease and aging. Med Roundtable Cardiovasc Ed 2011; 2(2): 99-106.
30
De Juan Pardo MA, Russo MT, Roque Sanchez MV. A hermeneutic phenomenological explorations of living in old age. Geriatr Nurs 2018; 39(1): 9-17.
31
Jin H, Kim Y, Rhie SJ. Factors affecting medication adherence in elderly people. Patient Prefer Adherence 2016; 10: 2117-25.
32
Tobiano G, Marshall A, Bucknall T, Chaboyer W. Patient participation in nursing care on medical wards: An integrative review. Int J Nurs Stud 2015; 52(6): 1107-20.
33
Kraskian-Mujembari A, Haghi-Asgarabadi F, Jomehri F. Determination of the psychometric properties of the aging perception questionnaire.
34
J Res Behav Sci 2017; 15(2): 142-50.
35
Robertson DA, Kenny RA. "I'm too old for that" The association between negative perceptions of aging and disengagement in later life. Pers Individ Dif 2016; 100: 114-9.
36
Robertson DA, Savva GM, King-Kallimanis BL, Kenny RA. Negative perceptions of aging and decline in walking speed: A self-fulfilling prophecy. PLoS One 2015; 10(4): e0123260.
37
Robertson DA, King-Kallimanis BL, Kenny RA. Negative perceptions of aging predict longitudinal decline in cognitive function. Psychol Aging 2016; 31(1): 71-81.
38
South SC, Boudreaux MJ, Oltmanns TF. The impact of personality disorders on longitudinal change in relationship satisfaction in long-term married couples. J Pers Disord 2019; 7-26.
39
Holt E, Joyce C, Dornelles A, Morisky D, Webber LS, Muntner P, et al. Sex differences in barriers to antihypertensive medication adherence: Findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc 2013; 61(4): 558-64.
40
Mertler CA, Reinhart RV. Advanced and multivariate statistical methods: Practical application and interpretation. Abingdon, UK: Taylor & Francis; 2016.
41
Gum AM, Ayalon L. Self-perceptions of aging mediate the longitudinal relationship of hopelessness and depressive symptoms. Int J Geriatr Psychiatry 2018; 33(4): 591-7.
42
Agronin M. Sexual dysfunction in older adults [Online]. [cited 2017]; Available from: URL: https://www.uptodate.com/contents/sexual-dysfunction-in-older-adults
43
Hart PD, Buck DJ. The effect of resistance training on health-related quality of life in older adults: Systematic review and meta-analysis. Health Promot Perspect 2019; 9(1): 1-12.
44
Liu C, Bai X. Handbook of theories of aging (3rd ed). China Journal of Social Work 2019; 12(1): 92-4.
45
Sinkovic M, Towler L. Sexual Aging: A Systematic review of qualitative research on the sexuality and sexual health of older adults. Qual Health Res 2019; 29(9): 1239-54.
46
Merghati-Khoei E, Pirak A, Yazdkhasti M, Rezasoltani P. Sexuality and elderly with chronic diseases: A review of the existing literature. J Res Med Sci 2016; 21: 136.
47
Parker K, Bull-Engelstad I, Aasebo W, von der Lippe N, Reier-Nilsen M, Os I, et al. Medication regimen complexity and medication adherence in elderly patients with chronic kidney disease. Hemodial Int 2019; 23(3): 333-42.
48
Yap AF, Thirumoorthy T, Kwan YH. Systematic review of the barriers affecting medication adherence in older adults. Geriatr Gerontol Int 2016; 16(10): 1093-101.
49
Koch G, Wakefield BJ, Wakefield DS. Barriers and facilitators to managing multiple chronic conditions: A systematic literature review. West
50
J Nurs Res 2015; 37(4): 498-516.
51
ORIGINAL_ARTICLE
Validation and responsiveness of the Persian version of HeartQoL questionnaire in cardiac rehabilitation after coronary artery bypass grafting: An observational study
BACKGROUND: Decision making and the quality of care provided for chronic diseases have been shown to improve through patient participation. The HeartQoL questionnaire is a core health-related quality of life (HRQOL) tool specifically designed for individuals with ischemic heart disease (IHD) who have undergone interventions such as cardiac rehabilitation (CR).METHODS: In this observational and multicenter study, 150 patients were recruited. The participants completed the HeartQoL, MacNew Heart Disease Questionnaire, and Short Form Health Survey (SF-36) on entering CR for validity assessment. The HeartQoL along with a Global Rating of Change (GRoC) scale (for responsiveness measurement) were completed by 100 participants 3 months later.RESULTS: The mean age of all participants in validity assessment was 61.87 ± 8.13 years. Cronbach’s alphas of the total scales ranged from 0.70 to 0.81 and of the subscales from 0.70 to 0.82. The Pearson correlation coefficient was used to determine construct validity; similar constructs were confirmed with correlation coefficients ranging from 0.50 to 0.69 and dissimilar constructs with correlation coefficients ranging from 0.28 to 0.29 (P < 0.010). The assessment of the responsiveness of the questionnaire indicated that the area under curve (AUC) was greater than 0.70 (range: 0.74 to 0.91) and the optimal cut-off point was 0.65.CONCLUSION: The Persian version of the HeartQoL questionnaire demonstrated satisfactory psychometric properties in the sample of participants admitted to CR after coronary artery bypass grafting (CABG). The present study results showed that the HRQOL can be used by clinicians and researchers in conjunction with other outcome measures to gain additional information about symptoms relevant to HRQOL in patients referred to CR and to evaluate change over time.
https://arya.mui.ac.ir/article_10738_685e7a3d63d8f969e61f96af6f5ee232.pdf
2020-09-09
170
177
10.22122/arya.v16i4.2098
Health-Related Quality of Life
Outcomes Assessment
Validity
Cardiac Rehabilitation
Maryam
Saba
saba@mailinator.com
1
PhD Candidate, Musculoskeletal Rehabilitation Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
AUTHOR
Shahin
Goharpey
shgoharpey@yahoo.com
2
Assistant Professor, Musculoskeletal Rehabilitation Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
LEAD_AUTHOR
Behrouz
Attarbashi Moghadam
attarbashi@mailinator.com
3
Associate Professor, Department of Physiotherapy, School of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Reza
Salehi
salehi@mailinator.com
4
Associate Professor, Rehabilitation Research Center, Department of Rehabilitation Management, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran
AUTHOR
Sayed Mohammadreza
Afshani
afshani@mailinator.com
5
Assistant Professor, Department of Cardiovascular Disease, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
AUTHOR
Tardif TC. Coronary artery disease in 2010. European Heart Journal Supplements 2010; 12(suppl_C): C2-C10.
1
Guilbert JJ. The world health report 2. Educ Health (Abingdon) 2003; 16(2): 230.
2
Ebrahimi M, Kazemi-Bajestani SM, Ghayour-Mobarhan M, Ferns GA. Coronary artery disease and its risk factors status in Iran: A review. Iran Red Crescent Med J 2011; 13(9): 610-23.
3
Cepeda-Valery B, Cheong AP, Lee A, Yan BP. Measuring health related quality of life in coronary heart disease: The importance of feeling well. Int J Cardiol 2011; 149(1): 4-9.
4
Anker SD, Agewall S, Borggrefe M, Calvert M, Jaime CJ, Cowie MR, et al. The importance of patient-reported outcomes: A call for their comprehensive integration in cardiovascular clinical trials. Eur Heart J 2014; 35(30): 2001-9.
5
Longtin Y, Sax H, Leape LL, Sheridan SE, Donaldson L, Pittet D. Patient participation: Current knowledge and applicability to patient safety. Mayo Clin Proc 2010; 85(1): 53-62.
6
European Medicines Agency. Regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products [Online]. [cited 2005]; Available from: URL:
7
https://www.ema.europa.eu/en/regulatory-guidance-use-health-related-quality-life-hrql-measures-evaluation-medicinal-products
8
U.S. Food and Drug. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims [Online]. [cited 2009]; Available from: URL:
9
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims
10
Krumholz HM, Peterson ED, Ayanian JZ, Chin MH, DeBusk RF, Goldman L, et al. Report of the National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease. Circulation 2005; 111(23): 3158-66.
11
Rumsfeld JS, Alexander KP, Goff DC Jr, Graham MM, Ho PM, Masoudi FA, et al. Cardiovascular health: The importance of measuring patient-reported health status: A scientific statement from the American Heart Association. Circulation 2013; 127(22): 2233-49.
12
Cooper JK, Kohlmann T, Michael JA, Haffer SC, Stevic M. Health outcomes. New quality measure for Medicare. Int J Qual Health Care 2001; 13(1): 9-16.
13
Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DL, et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: A clarification of its content. BMC Med Res Methodol 2010; 10: 22.
14
Verrill DE, Barton C, Beasley W, Lippard M, King CN. Six-minute walk performance and quality of life comparisons in North Carolina cardiac rehabilitation programs. Heart Lung 2003; 32(1): 41-51.
15
Oldridge N, Hofer S, McGee H, Conroy R, Doyle F, Saner H. The HeartQoL: Part I. Development of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur J Prev Cardiol 2014; 21(1): 90-7.
16
Gronset CN, Thygesen LC, Berg SK, Zangger G, Kristensen MS, Sibilitz KL, et al. Measuring HRQoL following heart valve surgery: The HeartQoL questionnaire is a valid and reliable core heart disease instrument. Qual Life Res 2019; 28(5): 1245-53.
17
Kristensen MS, Zwisler AD, Berg SK, Zangger G, Gronset CN, Risom SS, et al. Validating the HeartQoL questionnaire in patients with atrial fibrillation. Eur J Prev Cardiol 2016; 23(14): 1496-503.
18
Zangger G, Zwisler AD, Kikkenborg Berg S, Kristensen MS, Gronset CN, Uddin J, et al. Psychometric properties of HeartQoL, a core heart disease-specific health-related quality of life questionnaire, in Danish implantable cardioverter defibrillator recipients. Eur J Prev Cardiol 2018; 25(2): 142-9.
19
Hojskov IE, Moons P, Hansen NV, La Cour S, Olsen PS, Gluud C, et al. SheppHeartCABG trial-comprehensive early rehabilitation after coronary artery bypass grafting: A protocol for a randomised clinical trial. BMJ Open 2017; 7(1): e013038.
20
Oldridge N, Hofer S, McGee H, Conroy R, Doyle F, Saner H. The HeartQoL: Part II. Validation of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur J Prev Cardiol 2014; 21(1): 98-106.
21
Ranjandish F, Mahmoodi H, Shaghaghi A. Psychometric responsiveness of the health-related quality of life questionnaire (HeartQoL-P) in the Iranian post-myocardial infarction patients. Health Qual Life Outcomes 2019; 17(1): 10.
22
MacNew. Information [Online]. [cited 2020]; Available from: URL:
23
http://www.macnew.org/wp/information
24
Hofer S, Lim L, Guyatt G, Oldridge N. The MacNew Heart Disease health-related quality of life instrument: A summary. Health Qual Life Outcomes 2004; 2: 3.
25
Asadi-Lari M, Javadi HR, Melville M, Oldridge NB, Gray D. Adaptation of the MacNew quality of life questionnaire after myocardial infarction in an Iranian population. Health Qual Life Outcomes 2003; 1: 23.
26
Ware JE Jr. SF-36 health survey update. Spine (Phila Pa 1976) 2000; 25(24): 3130-9.
27
Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey (SF-36): Translation and validation study of the Iranian version. Qual Life Res 2005; 14(3): 875-82.
28
Kamper SJ, Maher CG, Mackay G. Global rating of change scales: A review of strengths and weaknesses and considerations for design. J Man Manip Ther 2009; 17(3): 163-70.
29
Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60(1): 34-42.
30
Aaronson N, Alonso J, Burnam A, Lohr KN, Patrick DL, Perrin E, et al. Assessing health status and quality-of-life instruments: Attributes and review criteria. Qual Life Res 2002; 11(3): 193-205.
31
Pettersen KI, Kvan E, Rollag A, Stavem K, Reikvam A. Health-related quality of life after myocardial infarction is associated with level of left ventricular ejection fraction. BMC Cardiovasc Disord 2008; 8: 28.
32
de Vet HC, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine: A practical guide. Cambridge, UK: Cambridge University Press; 2011.
33
Lehman LA, Velozo CA. Ability to detect change in patient function: Responsiveness designs and methods of calculation. J Hand Ther 2010; 23(4): 361-70.
34
Mukaka MM. Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med J 2012; 24(3): 69-71.
35
van Kampen DA, Willems WJ, van Beers LW, Castelein RM, Scholtes VA, Terwee CB. Determination and comparison of the smallest detectable change (SDC) and the minimal important change (MIC) of four-shoulder patient-reported outcome measures (PROMs). J Orthop Surg Res 2013; 8: 40.
36
Lee WL, Chinna K, Bulgiba A, Abdullah KL, Abidin IZ, Hofer S. Test-retest reliability of HeartQoL and its comparability to the MacNew heart disease health-related quality of life questionnaire. Qual Life Res 2016; 25(2): 351-7.
37
Oldridge N, Cho C, Thomas R, Low M, Hofer S. Validation of the English version of the heartqol health-related quality of life questionnaire in patients with coronary heart disease. J Cardiopulm Rehabil Prev 2018; 38(2): 92-9.
38
ORIGINAL_ARTICLE
Association between ambient fine particulate matter with blood pressure levels among Iranian individuals admitted for cardiac and respiratory diseases: Data from CAPACITY study
BACKGROUND: The relation between air pollution and cardiovascular diseases (CVDs) risk factors, especially blood pressure (BP) levels, has been less frequently assessed. The aim of this study was evaluating the association between air pollutants of less than 2.5 µm [particulate matter (PM2.5)] and BP indices among individuals admitted with CVDs and pulmonary diseases.METHODS: This cross-sectional study was in context of air pollution associated with hospitalization and mortality of CVDs and respiratory diseases (CAPACITY) study. Data of 792 Iranian patients referring to two hospitals in Isfahan, Iran, for cardiovascular or respiratory problems from March 2011 to March 2012 were used for analysis. BP indices including systolic BP (SBP), diastolic BP (DBP), and mean arterial pressure (MAP) were obtained from patients’ medical forms and mean PM2.5 concentrations during 24 hours prior to admission of each patient were obtained from Isfahan Department of Environment (DOE).RESULTS: Mean ± standard deviation (SD) of participants’ age were 62.5 ± 15.9 years. All BP indices on admission were significantly higher in women compared with men. Adjustment of all potential confounders including age, sex, temperature, wind speed, and dew point revealed that increasing one quartile in PM2.5 concentrations had been associated with 1.98 mmHg raising in SBP at the time of admission [95% confidence interval (CI) = 0.41-3.54, P = 0.010]. Women with cardiac diseases had higher all BP indices with increased PM2.5 concentration [SBP: β: 4.30, 95% CI = 0.90-7.70, P = 0.010; DBP: β: 1.89, 95% CI = 0.09-3.69, P = 0.040; MAP: β: 3.09, 95% CI = 0.68-5.51, P= 0.010, respectively).CONCLUSION: Our findings suggest that increasing PM2.5 concentration has been positively associated with raising SBP in total population and all BP indices among women with cardiac problems at admission time. Several comprehensive studies are required for confirming these relations.
https://arya.mui.ac.ir/article_10739_92aa192106ea434d7b2deb942fee9eb3.pdf
2020-09-09
178
184
10.22122/arya.v16i4.2032
Particulate Matter
Blood Pressure
Air Pollutants
Air Pollution
Alireza
Khosravi
alirezakhosravif@gmail.com
1
Professor, Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Hamid Reza
Rajabi
rajabi@mailinator.com
2
Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Mehrbod
Vakhshoori
vakhshoori@mailinator.com
3
General Practitioner, Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Katayoun
Rabiei
rabiei@mailinator.com
4
General Practitioner, Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Sayed Mohsen
Hosseini
hosseini@mailinator.com
5
Professor, Department of Biostatics and Epidemiology, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Asieh
Mansouri
mansouri.arn@gmail.com
6
Assistant Professor, Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Farshad
Roghani-Dehkordi
roghani@mailinator.com
7
Professor, Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Jamshid
Najafian
jamshid_najafian@yahoo.com
8
Associate Professor, Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Mojtaba
Rahimi
rahimi@mailinator.com
9
Associate Professor, Department of Anesthesiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Tohid
Jafari-Koshki
jafari@mailinator.com
10
Molecular Medicine Research Center, Department of Statistics and Epidemiology, School of Health, Tabriz University of Medical Sciences, Tabriz, Iran
AUTHOR
Babak
Sadeghian
sadeghian@mailinator.com
11
Central Laboratory and Air Pollution Monitoring, Isfahan Province Environmental Monitoring Center, Isfahan Department of Environment, Isfahan, Iran
AUTHOR
Mansour
Shishehforoush
shishehforoush@mailinator.com
12
Isfahan Disaster Management Office, Isfahan Governor Office, Isfahan, Iran
AUTHOR
Ahmadreza
Lahijanzadeh
lahijanzadeh@mailinator.com
13
Khouzestan Department of Environment, Ahvaz, Iran
AUTHOR
Marzieh
Taheri
taheri@mailinator.com
14
Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Nizal
Sarrafzadegan
nsarrafzadegan@gmail.com
15
Professor, Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
LEAD_AUTHOR
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360(9349): 1903-13.
1
Britton KA, Gaziano JM, Djousse L. Normal systolic blood pressure and risk of heart failure in US male physicians. Eur J Heart Fail 2009; 11(12): 1129-34.
2
Pickering G. Hypertension. Definitions, natural histories and consequences. Am J Med 1972; 52(5): 570-83.
3
Nowka MR, Bard RL, Rubenfire M, Jackson EA, Brook RD. Patient awareness of the risks for heart disease posed by air pollution. Prog Cardiovasc Dis 2011; 53(5): 379-84.
4
World Health Organization. WHO urban outdoor air pollution database. Geneva, Switzerland: WHO; 2011.
5
Franchini M, Mannucci PM. Particulate air pollution and cardiovascular risk: Short-term and long-term effects. Semin Thromb Hemost 2009; 35(7): 665-70.
6
Brunekreef B, Holgate ST. Air pollution and health. Lancet 2002; 360(9341): 1233-42.
7
Shah AS, Langrish JP, Nair H, McAllister DA, Hunter AL, Donaldson K. Global association of air pollution and heart failure: A systematic review and meta-analysis. Lancet 2013; 383(9897): 1039-48.
8
Franchini M, Mannucci PM. Air pollution and cardiovascular disease. Thromb Res 2012; 129(3): 230-4.
9
Zanobetti A, Canner MJ, Stone PH, Schwartz J, Sher D, Eagan-Bengston E, et al. Ambient pollution and blood pressure in cardiac rehabilitation patients. Circulation 2004; 110(15): 2184-9.
10
Urch B, Silverman F, Corey P, Brook JR, Lukic KZ, Rajagopalan S, et al. Acute blood pressure responses in healthy adults during controlled air pollution exposures. Environ Health Perspect 2005; 113(8): 1052-5.
11
Peters A, Liu E, Verrier RL, Schwartz J, Gold DR, Mittleman M, et al. Air pollution and incidence of cardiac arrhythmia. Epidemiology 2000; 11(1): 11-7.
12
Rich DQ, Schwartz J, Mittleman MA, Link M, Luttmann-Gibson H, Catalano PJ, et al. Association of short-term ambient air pollution concentrations and ventricular arrhythmias. Am J Epidemiol 2005; 161(12): 1123-32.
13
Yang BY, Markevych I, Bloom MS, Heinrich J, Guo Y, Morawska L, et al. Community greenness, blood pressure, and hypertension in urban dwellers: The 33 Communities Chinese Health Study. Environ Int 2019; 126: 727-34.
14
Schwarze PE, Ovrevik J, Lag M, Refsnes M, Nafstad P, Hetland RB, et al. Particulate matter properties and health effects: consistency of epidemiological and toxicological studies. Hum Exp Toxicol 2006; 25(10): 559-79.
15
Brook RD. Cardiovascular effects of air pollution. Clin Sci (Lond) 2008; 115(6): 175-87.
16
Rabiei K, Hosseini SM, Sadeghi E, Jafari-Koshki T, Rahimi M, Shishehforoush M, et al. Air pollution and cardiovascular and respiratory disease: Rationale and methodology of CAPACITY study. ARYA Atheroscler 2017; 13(6): 264-73.
17
Hicken MT, Dvonch JT, Schulz AJ, Mentz G, Max P. Fine particulate matter air pollution and blood pressure: The modifying role of psychosocial stress. Environ Res 2014; 133: 195-203.
18
Liang R, Zhang B, Zhao X, Ruan Y, Lian H, Fan Z. Effect of exposure to PM2.5 on blood pressure: A systematic review and meta-analysis. J Hypertens 2014; 32(11): 2130-40.
19
Auchincloss AH, Diez Roux AV, Dvonch JT, Brown PL, Barr RG, Daviglus ML, et al. Associations between recent exposure to ambient fine particulate matter and blood pressure in the Multi-ethnic Study of Atherosclerosis (MESA). Environ Health Perspect 2008; 116(4): 486-91.
20
Chen LH, Knutsen SF, Shavlik D, Beeson WL, Petersen F, Ghamsary M, et al. The association between fatal coronary heart disease and ambient particulate air pollution: Are females at greater risk? Environ Health Perspect 2005; 113(12): 1723-9.
21
Kim CS, Hu SC. Regional deposition of inhaled particles in human lungs: Comparison between men and women. J Appl Physiol (1985) 1998; 84(6): 1834-44.
22
Sorensen M, Daneshvar B, Hansen M, Dragsted LO, Hertel O, Knudsen L, et al. Personal PM2.5 exposure and markers of oxidative stress in blood. Environ Health Perspect 2003; 111(2): 161-6.
23
Baccarelli A, Barretta F, Dou C, Zhang X, McCracken JP, Diaz A, et al. Effects of particulate air pollution on blood pressure in a highly exposed population in Beijing, China: A repeated-measure study. Environ Health 2011; 10: 108.
24
Wu S, Deng F, Huang J, Wang H, Shima M, Wang X, et al. Blood pressure changes and chemical constituents of particulate air pollution: Results from the healthy volunteer natural relocation (HVNR) study. Environ Health Perspect 2013; 121(1): 66-72.
25
Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, et al. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation 2010; 121(21): 2331-78.
26
Cakmak S, Dales R, Leech J, Liu L. The influence
27
of air pollution on cardiovascular and pulmonary function and exercise capacity: Canadian Health Measures Survey (CHMS). Environ Res 2011; 111(8): 1309-12.
28
Dai L, Koutrakis P, Coull BA, Sparrow D, Vokonas PS, Schwartz JD. Use of the adaptive lasso method to identify PM2.5 components associated with blood pressure in elderly men: The veterans affairs normative aging study. Environ Health Perspect 2016; 124(1): 120-5.
29
Zhang H, Qian J, Zhao H, Wang J, Zhu H, Zhou Y, et al. A study of the association between atmospheric particulate matter and blood pressure in the population. Blood Press 2016; 25(3): 169-76.
30
Yang BY, Qian Z, Howard SW, Vaughn MG, Fan SJ, Liu KK, et al. Global association between ambient air pollution and blood pressure: A systematic review and meta-analysis. Environ Pollut 2018; 235: 576-88.
31
Pieters N, Koppen G, Van Poppel M, De Prins S, Cox B, Dons E, et al. Blood Pressure and Same-Day Exposure to Air Pollution at School: Associations with Nano-Sized to Coarse PM in Children. Environ Health Perspect 2015; 123(7): 737-42.
32
ORIGINAL_ARTICLE
Depressive symptoms and major adverse cardiovascular events: 12-month follow-up in patients undergoing angiography
BACKGROUND: Depression is closely related to coronary artery disease (CAD). However, the association of depression before angiography with major adverse cardiovascular event (MACE) is still unknown.METHODS: In a prospective cohort study, 410 patients underwent angiography for the first time between 2016 and 2017 in Dr. Heshmat Hospital, Rasht, Iran. Demographic and medical information were collected and depressive symptoms were assessed using Beck Depression Inventory-II (BDI-II). The patients were followed for one year after angiography. Chi-square test and analysis of variance (ANOVA) were performed to compare demographic and clinical characteristics of patients between different levels of depressive symptoms. Multiple Cox regression analysis was performed to assess the association between depression symptoms before angiography and MACE rate controlled for the effect of confounders.RESULTS: Of 410 patients, follow-up data were available for 380 (95%) patients. the MACE occurred in 134 (35%) patients. Depressive symptoms were observed in 42% of patients. Based on multivariable Cox regression analysis, adjusted for CAD severity, the risk of one-year MACE occurrence in patients with mild, moderate, and severe depressive symptoms was 1.96 [95% confidence interval (CI) for hazard ratio (HR): 1.30-2.94], 1.88 (95% CI for HR: 1.15-3.09), and 2.81 (95% CI for HR: 1.56-5.06) times that of patients without depressive symptoms, respectively. Depression in patients before angiography increased the risk of MACE up to 2.045 times.CONCLUSION: The results showed that MACE in patients with depression was more than patients without depression. MACE in different levels of depression (mild, moderate, severe) was not significantly different.
https://arya.mui.ac.ir/article_10740_9eb75d3abca03e9fed0c29eaca22c74a.pdf
2020-09-09
185
191
10.22122/arya.v16i4.1955
Depression
Angiography
Coronary Artery Disease
Heidar
Dadkhah-Tirani
dadkhah@mailinator.com
1
Associate Professor, Cardiovascular Diseases Research Center AND Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
AUTHOR
Arsalan
Salari
salari@mailinator.com
2
Professor, Cardiovascular Diseases Research Center AND Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
AUTHOR
Asieh
Ashouri
ashouri@mailinator.com
3
Assistant Professor, Cardiovascular Diseases Research Center AND Department of Cardiology, Heshmat Hospital, School of Medicine AND Research Center of Health and Environment, School of Health, Guilan University of Medical Sciences, Rasht, Iran
AUTHOR
Azam
Nouri-Saeed
nouri@mailinator.com
4
Cardiovascular Diseases Research Center AND Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
AUTHOR
Arezoo
Javadzadeh-Moghtader
arezoo_javadzade@yahoo.com
5
Cardiovascular Diseases Research Center AND Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
LEAD_AUTHOR
Connerney I, Sloan RP, Shapiro PA, Bagiella E, Seckman C. Depression is associated with increased mortality 10 years after coronary artery bypass surgery. Psychosom Med 2010; 72(9): 874-81.
1
Damen NL, Versteeg H, Boersma E, Serruys PW, van Geuns RJ, Denollet J, et al. Depression is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: Results from the RESEARCH registry. Int J Cardiol 2013; 167(6): 2496-501.
2
Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis of 25 years of research. Gen Hosp Psychiatry 2011; 33(3): 203-16.
3
Zuidersma M, Conradi HJ, van Melle JP, Ormel J, de Jonge P. Self-reported depressive symptoms, diagnosed clinical depression and cardiac morbidity and mortality after myocardial infarction. Int
4
J Cardiol 2013; 167(6): 2775-80.
5
Murphy B, Rogerson M, Worcester M, Elliott P, Higgins R, Le Grande M, et al. Predicting mortality 12 years after an acute cardiac event: Comparison between inhospital and 2-month assessment of depressive symptoms in women. J Cardiopulm Rehabil Prev 2013; 33(3): 160-7.
6
Elderon L, Whooley MA. Depression and cardiovascular disease. Prog Cardiovasc Dis 2013; 55(6): 511-23.
7
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004; 364(9438): 937-52.
8
Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, et al. Depression as a risk factor for coronary artery disease: Evidence, mechanisms, and treatment. Psychosom Med 2004; 66(3): 305-15.
9
Carney RM, Freedland KE, Steinmeyer B, Blumenthal JA, de JP, Davidson KW, et al. History of depression and survival after acute myocardial infarction. Psychosom Med 2009; 71(3): 253-9.
10
Parakh K, Thombs BD, Fauerbach JA, Bush DE, Ziegelstein RC. Effect of depression on late (8 years) mortality after myocardial infarction. Am J Cardiol 2008; 101(5): 602-6.
11
Myers V, Gerber Y, Benyamini Y, Goldbourt U, Drory Y. Post-myocardial infarction depression: Increased hospital admissions and reduced adoption of secondary prevention measures-a longitudinal study. J Psychosom Res 2012; 72(1): 5-10.
12
Reese RL, Freedland KE, Steinmeyer BC, Rich MW, Rackley JW, Carney RM. Depression and rehospitalization following acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2011; 4(6): 626-33.
13
Sullivan MD, LaCroix AZ, Spertus JA, Hecht J, Russo J. Depression predicts revascularization procedures for 5 years after coronary angiography. Psychosom Med 2003; 65(2): 229-36.
14
Park MW, Kim JH, Her SH, Cho JS, Choi MS, Gweon TG, et al. Effects of percutaneous coronary intervention on depressive symptoms in chronic stable angina patients. Psychiatry Investig 2012; 9(3): 252-6.
15
Hance M, Carney RM, Freedland KE, Skala J. Depression in patients with coronary heart disease. A 12-month follow-up. Gen Hosp Psychiatry 1996; 18(1): 61-5.
16
Tsai IT, Wang CP, Lu YC, Hung WC, Wu CC, Lu LF, et al. The burden of major adverse cardiac events in patients with coronary artery disease. BMC Cardiovasc Disord 2017; 17(1): 1.
17
Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996
18
Beck At, Ward Ch, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-71.
19
Wang ZJ, Guo M, Si TM, Jiang MM, Liu SM, Liu YY, et al. Association of depression with adverse cardiovascular events after percutaneous coronary intervention. Coron Artery Dis 2013; 24(7): 589-95.
20
Ghassemzadeh H, Mojtabai R, Karamghadiri N, Ebrahimkhani N. Psychometric properties of a Persian-language version of the Beck Depression Inventory-Second edition: BDI-II-PERSIAN. Depress Anxiety 2005; 21(4): 185-92.
21
Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993; 270(15): 1819-25.
22
Li XM, Li TT, Cong HL, Guo ZG, Song JH, Zhao R, et al. Impact of depression on prognosis of patients with coronary heart disease undergoing revascularization. Zhonghua Xin Xue Guan Bing Za Zhi 2012; 40(2): 99-103.
23
Frasure-Smith N, Lesperance F, Irwin MR, Sauve C, Lesperance J, Theroux P. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry 2007; 62(4): 302-8.
24
Meyer T, Hussein S, Lange HW, Herrmann-Lingen C. Anxiety is associated with a reduction in both mortality and major adverse cardiovascular events five years after coronary stenting. Eur J Prev Cardiol 2015; 22(1): 75-82.
25
Rothenbacher D, Hahmann H, Wusten B, Koenig W, Brenner H. Symptoms of anxiety and depression in patients with stable coronary heart disease: Prognostic value and consideration of pathogenetic links. Eur J Cardiovasc Prev Rehabil 2007; 14(4): 547-54.
26
Shibeshi WA, Young-Xu Y, Blatt CM. Anxiety worsens prognosis in patients with coronary artery disease. J Am Coll Cardiol 2007; 49(20): 2021-7.
27
Pelletier R, Bacon SL, Arsenault A, Dupuis J, Laurin C, Blais L, et al. Relative associations between depression and anxiety on adverse cardiovascular events: Does a history of coronary artery disease matter? A prospective observational study. BMJ Open 2015; 5(12): e006582.
28
Huffman JC, Celano CM, Beach SR, Motiwala SR, Januzzi JL. Depression and cardiac disease: Epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol 2013; 2013: 695925.
29
ORIGINAL_ARTICLE
The role of the characteristics of exercise-based cardiac rehabilitation program in the improvement of lipid profile level: A systematic review and meta-analysis
BACKGROUND: The current study was aimed at updating prior systematic review and meta-analyses (SRMA) in order to determine the effects of supervised exercise-based cardiac rehabilitation (EBCR) and introduce a suitable exercise protocol for lipid profile changes in patients with cardiovascular disease (CVD).METHODS: PubMed, Scopus, and Web of Science databases were searched from 1980 to December 2018. All published, randomized controlled trials (RCTs) reporting the efficacy of supervised EBCR in patients with CVD and measuring at least 1 component of lipid profile were included. The quality of articles was assessed based on the Physiotherapy Evidence Database (PEDro) scale. Random effect model was used to calculate the effect size of post-intervention data.RESULTS: Initially 774 RCTs were reviewed, 14 of them were included in the study. In comparison with the control group, supervised EBCR was associated with higher serum levels of high-density lipoprotein (HDL) [weight mean difference (WMD): 1.297; 95% confidence interval (CI): -1.620, 4.214] and lower serum level of low-density lipoprotein (LDL) (WMD: -7.797; 95%CI: -14.005, -1.588), total cholesterol (TC) (WMD: -11.029; 95%CI: -20.716, -1.342), and triglyceride (TG) (WMD: -14.602; 95%CI: -28.992, -0.212).CONCLUSION: It seems that EBCR is correlated with an insignificant increase in HDL serum level and a significant decrease in LDL, TC, and TG serum levels. Considering subgroup analysis results, it is suggested that long duration, moderate exercise volume (EV), and combination of aerobic exercise (AE) and resistance exercise (RE) be used to improve HDL and TG serum levels. Short duration, high EV, and AE+RE seem to significantly reduce LDL serum level. Moreover, moderate EV is associated with a significant reduction in TC level.
https://arya.mui.ac.ir/article_10741_128cc94b399b362249bb77401de9ccad.pdf
2020-09-09
192
207
10.22122/arya.v16i4.2123
Cardiac Rehabilitation
Cardiovascular Diseases
Exercise
Lipids
Meta-Analysis
Mohammad
Javaherian
javaherian@mailinator.com
1
PhD Candidate, Liver Transplantation Research Center, Imam Khomeini Hospital Complex AND Department of Physiotherapy, School of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Narges
Dabbaghipour
dabbaghipour@mailinator.com
2
Department of Physiotherapy, School of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Zinat
Mohammadpour
mohammadpour@mailinator.com
3
Liver Transplantation Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Behrouz
Attarbashi Moghadam
attarbashi@tums.ac.ir
4
Associate Professor, Department of Physiotherapy, School of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran
LEAD_AUTHOR
Bennett SJ, Sauve MJ. Cognitive deficits in patients with heart failure: A review of the literature. J Cardiovasc Nurs 2003; 18(3): 219-42.
1
Roth GA, Huffman MD, Moran AE, Feigin V, Mensah GA, Naghavi M, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation 2015; 132(17): 1667-78.
2
Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med 2001; 345(12): 892-902.
3
World Health Organization. Obesity: Preventing and managing the global epidemic. Geneva, Switzerland: WHO; 2000.
4
Thompson DR, Jenkinson C, Roebuck A, Lewin RJ, Boyle RM, Chandola T. Development and validation of a short measure of health status for individuals with acute myocardial infarction: The myocardial infarction dimensional assessment scale (MIDAS). Qual Life Res 2002; 11(6): 535-43.
5
Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Executive summary: Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 2012; 125(1): 188-97.
6
Yeates K, Lohfeld L, Sleeth J, Morales F, Rajkotia Y, Ogedegbe O. A global perspective on cardiovascular disease in vulnerable populations. Can J Cardiol 2015; 31(9): 1081-93.
7
Ades PA, Coello CE. Effects of exercise and cardiac rehabilitation on cardiovascular outcomes. Med Clin North Am 2000; 84(1): 251-xi.
8
Leon AS, Franklin BA, Costa F, Balady GJ, Berra KA, Stewart KJ, et al. Cardiac rehabilitation and secondary prevention of coronary heart disease: An American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation. Circulation 2005; 111(3): 369-76.
9
Chen JT, Lin TH, Voon WC, Lai WT, Huang MH, Sheu SH, et al. Beneficial effects of home-based cardiac rehabilitation on metabolic profiles in coronary heart-disease patients. Kaohsiung J Med Sci 2016; 32(5): 267-75.
10
Heran BS, Chen JM, Ebrahim S, Moxham T, Oldridge N, Rees K, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2011; (7): CD001800.
11
Clark AM, Hartling L, Vandermeer B, McAlister FA. Meta-analysis: Secondary prevention programs for patients with coronary artery disease. Ann Intern Med 2005; 143(9): 659-72.
12
Orozco-Beltran D, Gil-Guillen VF, Redon J, Martin-Moreno JM, Pallares-Carratala V, Navarro-Perez J, et al. Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study. PLoS One 2017; 12(10): e0186196.
13
Redfern J, Briffa T, Ellis E, Freedman SB. Patient-centered modular secondary prevention following acute coronary syndrome: A randomized controlled trial. J Cardiopulm Rehabil Prev 2008; 28(2): 107-15.
14
Yates BC, Rowland S, Mancuso K, Kupzyk KA, Norman JF, Shurmur S, et al. Reducing cardiovascular risk in spouses of cardiac patients: A randomized controlled trial. West J Nurs Res 2015; 37(1): 85-102.
15
Jolliffe JA, Rees K, Taylor RS, Thompson D, Oldridge N, Ebrahim S. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2001; (1): CD001800.
16
Chen YC, Tsai JC, Liou YM, Chan P. Effectiveness of endurance exercise training in patients with coronary artery disease: A meta-analysis of randomised controlled trials. Eur J Cardiovasc Nurs 2017; 16(5): 397-408.
17
Lysen LK, Israel DA. Nutrition in weight management. In: Mahan LK, Escott-Stump S, Raymond JL, Krause MV, Editors. Krause's food & the nutrition care process. Philadelphia, PA: Elsevier Health Sciences; 2012. p. 462-88.
18
Furuyama F, Koba S, Yokota Y, Tsunoda F, Shoji M, Kobayashi Y. Effects of Cardiac Rehabilitation on High-Density Lipoprotein-mediated Cholesterol Efflux Capacity and Paraoxonase-1 Activity in Patients with Acute Coronary Syndrome. J Atheroscler Thromb 2018; 25(2): 153-69.
19
Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. Hobiken, NJ: John Wiley & Sons; 2011.
20
Berg A. Influence of physical exercise therapy (heart groups) on cardiovascular and metabolic functions in patients after myocardial-infarction. Herz Kreislauf 1985; 17(10): 522-8.
21
Bigi R, Corradetti C, Gemma S, Occhi G, Partesana N, Curti PN. Short-term effect of a cardiac rehabilitation program on high-density lipoprotein-cholesterol of male survivors of myocardial infarction. Minerva Cardioangiol 1985; 33(3): 127-34.
22
Li S, Wu X, Sun Q, He ZS, Ru LS, Yang L, et al. Effects of a two-week, hospitalized cardiac rehabilitation program on serum lipid profiles, quality of life and psychological status in patients with acute myocardial infarction. Chinese Journal of Rehabilitation Medicine 2006; 21(8): 696.
23
Aronov DM, Krasnitskii VB, Bubnova MG, Posdniakov I, Ioseliani DV, Shchegol'kov AN, et al. Exercise in outpatient complex rehabilitation and secondary prophylaxis in patients with ischemic heart disease after acute coronary events (a cooperative trial in Russia). Ter Arkh 2006; 78(9): 33-8.
24
Aronov DM, Krasnitskii VB, Bubnova MG, Pozdniakov I, Ioseliani DG, Shchegol'kov AN, et al. Physical training at ambulatory-polyclinical stage in complex rehabilitation and secondary prevention of patients with ischemic heart disease after acute incidents. Effect on physical working capacity, hemodynamics, blood lipids, clinical course and prognosis (Russian cooperative study). Kardiologiia 2009; 49(3): 49-56.
25
Korzeniowska-Kubacka I, Piotrowicz R. Influence of exercise training on physical capacity, lipid profile and return to work of women after myocardial infarction. Folia Cardiol 2004; 10: 719-25.
26
Ghroubi S, Elleuch W, Abid L, Kammoun S, Elleuch MH. Cardiac rehabilitation, coronary stenting and myocardial infarction. J Readapt Med 2014; 34(4): 173-81. [In French].
27
Wosornu D, Bedford D, Ballantyne D. A comparison of the effects of strength and aerobic exercise training on exercise capacity and lipids after coronary artery bypass surgery. Eur Heart J 1996; 17(6): 854-63.
28
Belardinelli R, Paolini I, Cianci G, Piva R, Georgiou D, Purcaro A. Exercise training intervention after coronary angioplasty: the ETICA trial. J Am Coll Cardiol 2001; 37(7): 1891-900.
29
Yu CM, Li LS, Ho HH, Lau CP. Long-term changes in exercise capacity, quality of life, body anthropometry, and lipid profiles after a cardiac rehabilitation program in obese patients with coronary heart disease. Am J Cardiol 2003; 91(3): 321-5.
30
Vona M, Rossi A, Capodaglio P, Rizzo S, Servi P, De Marchi M, et al. Impact of physical training and detraining on endothelium-dependent vasodilation in patients with recent acute myocardial infarction. Am Heart J 2004; 147(6): 1039-46.
31
Volaklis KA, Spassis AT, Tokmakidis SP. Land versus water exercise in patients with coronary artery disease: Eeffects on body composition, blood lipids, and physical fitness. Am Heart J 2007; 154(3): 560-6.
32
Balen S, Vukelic-Damijani N, Persic V, Ruzic A, Miletic B, Samardiija M, et al. Anti-inflammatory effects of exercise training in the early period after myocardial infarction. Coll Antropol 2008; 32(1): 285-91.
33
Seki E, Watanabe Y, Shimada K, Sunayama S, Onishi T, Kawakami K, et al. Effects of a phase III cardiac rehabilitation program on physical status and lipid profiles in elderly patients with coronary artery disease: Juntendo Cardiac Rehabilitation Program (J-CARP). Circ J 2008; 72(8): 1230-4.
34
Luk TH, Dai YL, Siu CW, Yiu KH, Chan HT, Lee SW, et al. Effect of exercise training on vascular endothelial function in patients with stable coronary artery disease: A randomized controlled trial. Eur J Prev Cardiol 2012; 19(4): 830-9.
35
Aksoy S, Findikoglu G, Ardic F, Rota S, Dursunoglu D. Effect of 10-week supervised moderate-intensity intermittent vs. continuous aerobic exercise programs on vascular adhesion molecules in patients with heart failure. Am J Phys Med Rehabil 2015; 94(10 Suppl 1): 898-911.
36
Hassan AM, El Nahas NG. Efficacy of cardiac rehabilitation after percutaneous coronary intervention. Int J PharmTech Res 2016; 9: 134-41.
37
Tamburus NY, Kunz VC, Salviati MR, Castello S, V, Catai AM, Da SE. Interval training based on ventilatory anaerobic threshold improves aerobic functional capacity and metabolic profile: a randomized controlled trial in coronary artery disease patients. Eur J Phys Rehabil Med 2016; 52(1): 1-11.
38
Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, et al. Exercise-based rehabilitation for patients with coronary heart disease: Systematic review and meta-analysis of randomized controlled trials. Am J Med 2004; 116(10): 682-92.
39
Oldridge N. Exercise-based cardiac rehabilitation in patients with coronary heart disease: Meta-analysis outcomes revisited. Future Cardiol 2012; 8(5): 729-51.
40
Lawler PR, Filion KB, Eisenberg MJ. Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: A systematic review and meta-analysis of randomized controlled trials. Am Heart J 2011; 162(4): 571-84.
41
Anderson L, Oldridge N, Thompson DR, Zwisler
42
AD, Rees K, Martin N, et al. Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis.
43
J Am Coll Cardiol 2016; 67(1): 1-12.
44
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342(3): 145-53.
45
Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003; 362(9386): 782-8.
46
Dor-Haim H, Barak S, Horowitz M, Yaakobi E, Katzburg S, Swissa M, et al. Improvement in cardiac dysfunction with a novel circuit training method combining simultaneous aerobic-resistance exercises. A randomized trial. PLoS One 2018; 13(1): e0188551.
47
Pierson LM, Herbert WG, Norton HJ, Kiebzak GM, Griffith P, Fedor JM, et al. Effects of combined aerobic and resistance training versus aerobic training alone in cardiac rehabilitation. J Cardiopulm Rehabil 2001; 21(2): 101-10.
48
ORIGINAL_ARTICLE
A case series of pulmonary hypertension in small infants with atrial septal defect
BACKGROUND: Atrial septal defect (ASD) is one of the most common congenital heart defects (CHDs) with prevalence of 8% to 10% in children with CHD and incidence of 56 per 100000 live births. It is categorized according to the defect site in which the most common form is secundum ASD (ASD2) with the defect in the central part of the atrial septum.CASE REPORT: In our case series, we evaluated five children aged under one year old with ASD2 and pulmonary hypertension (PH). All the patients were referred for surgical ASD closure. Their PH was improved and the size of right atrium (RA) and right ventricle (RV) became normal during the follow-up and one year after the surgery all of them had normal pulmonary artery pressure (PAP) with normal RA and RV size.CONCLUSION: According to our study and those done by others, the prevalence of PH in infants with ASD is low, but when this combination is found without any other CHD, ASD closure should be considered.
https://arya.mui.ac.ir/article_10742_d4fd32529b294e605e3701c2ad4c78fc.pdf
2020-09-09
208
210
10.22122/arya.v16i4.2157
Atrial Septal Defect
Pulmonary Hypertension
Congenital Heart Defects
Infant
Mohammad Reza
Sabri
sabri@mailinator.com
1
Professor, Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Chehreh
Mahdavi
chehreh_m@yahoo.com
2
Assistant Professor, Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
LEAD_AUTHOR
Hamid
Bigdelian
bigdelian@mailinator.com
3
Associate Professor, Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Ali Reza
Ahmadi
alirezaahmadi@med.mui.ac.ir
4
Associate Professor, Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Mehdi
Ghaderian
ghaderian@mailinator.com
5
Associate Professor, Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Bahar
Dehghan
dehghan@mailinator.com
6
Assistant Professor, Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Sachdeva R. Atrial septal defects. In: Allen HD, Shaddy RE, Penny DJ, Feltes TF, Cetta F, Editors. Moss & Adams' heart disease in infants, children, and adolescents, including the fetus and young adult. Philadelphia, PA: Wolters Kluwer; 2016. p. 739-43.
1
Dunbar I. Pediatric pulmonary hypertension. In: Allen HD, Shaddy RE, Penny DJ, Feltes TF, Cetta F, Editors. Moss & Adams' heart disease in infants, children, and adolescents, including the fetus and young adult. Philadelphia, PA: Wolters Kluwer; 2016. p. 1519.
2
Goetschmann S, Dibernardo S, Steinmann H, Pavlovic M, Sekarski N, Pfammatter JP. Frequency of severe pulmonary hypertension complicating "isolated" atrial septal defect in infancy. Am J Cardiol 2008; 102(3): 340-2.
3
Vogel M, Berger F, Kramer A, Alexi-Meshkishvili V, Lange PE. Incidence of secondary pulmonary hypertension in adults with atrial septal or sinus venosus defects. Heart 1999; 82(1): 30-3.
4
Vyas-Read S, Guglani L, Shankar P, Travers C, Kanaan U. Atrial septal defects accelerate pulmonary hypertension diagnoses in premature infants. Front Pediatr 2018; 6: 342.
5
Post MC. Association between pulmonary hypertension and an atrial septal defect. Neth Heart J 2013; 21(7-8): 331-2.
6
Lange SA, Braun MU, Schoen SP, Strasser RH. Latent pulmonary hypertension in atrial septal defect: Dynamic stress echocardiography reveals unapparent pulmonary hypertension and confirms rapid normalisation after ASD closure. Neth Heart J 2013; 21(7-8): 333-43.
7
ORIGINAL_ARTICLE
Adult patients with congenital heart disease during the Coronavirus disease 2019 epidemics
This article does not have an abstract
https://arya.mui.ac.ir/article_10743_ba600a5ea45e63c29bd9d531e8f0765a.pdf
2020-09-09
211
212
10.22122/arya.v16i4.2177
Maryam
Aliramezany
maliramezany@yahoo.com
1
Assistant Professor, Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences Kerman, Iran
LEAD_AUTHOR
Tan W, Aboulhosn J. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease. Int J Cardiol 2020; 309: 70-7.
1
Neidenbach RC, Lummert E, Vigl M, Zachoval R, Fischereder M, Engelhardt A, et al. Non-cardiac comorbidities in adults with inherited and congenital heart disease: Report from a single center experience of more than 800 consecutive patients. Cardiovasc Diagn Ther 2018; 8(4): 423-31.
2
Khajali Z, Maleki M, Amin A, Saedi S, Arabian M, Moosazadeh M, et al. Prevalence of cardiac dysfunction among adult patients with congenital heart disease: A single-center investigation. Iran Heart J 2019; 20(3): 12-9.
3
Alonso-Gonzalez R, Borgia F, Diller GP, Inuzuka R, Kempny A, Martinez-Naharro A, et al. Abnormal lung function in adults with congenital heart disease: Prevalence, relation to cardiac anatomy, and association with survival. Circulation 2013; 127(8): 882-90.
4